Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 401–500 of 1,004
International Liver Transplantation Society practice guideline update on portopulmonary hypertension
DuBrock, H. M., Savale, L., Sitbon, O., Raevens, S., Kawut, S. M., Fallon, M. B., Heimbach, J. K., Chadha, R., Crespo, G., Ramsay, M. A. E., et al. (2025) · Liver Transplantation · doi:10.1097/lvt.0000000000000600 · Cited by 42
Self-citationPulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
El‐Dabh, A., & Acharya, D. (2019) · Pulmonary Circulation · doi:10.1177/2045894019865704 · Cited by 42
Zhang, L., Bai, Y., Yan, P., He, T., Liu, B., Wu, S., Qian, Z., Li, C., Cao, Y., & Zhang, M. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10070-w · Cited by 42
Fujimoto, S., Fujita, Y., Kadota, T., Araya, J., & Kuwano, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.619697 · Cited by 42
AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling
Zhao, Q., Song, P., & Zou, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691585 · Cited by 42
Spikes, L. A., Bajwa, A. A., Burger, C. D., Desai, S. V., Eggert, M. S., El‐Kersh, K., Fisher, M. R., Johri, S., Joly, J. M., Mehta, J. P., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12063 · Cited by 42
Drug Treatment of Pulmonary Hypertension in Children
Avitabile, C. M., Vorhies, E. E., & Ivy, D. D. (2020) · Pediatric Drugs · doi:10.1007/s40272-019-00374-2 · Cited by 42
DNA Damage and Repair in Pulmonary Arterial Hypertension
Sharma, S., & Aldred, M. A. (2020) · Genes · doi:10.3390/genes11101224 · Cited by 41
The Roles of CCN1/CYR61 in Pulmonary Diseases
Zhu, Y., Almuntashiri, S., Han, Y., Wang, X., Somanath, P. R., & Zhang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217810 · Cited by 41
Bermejo, J., González‐Mansilla, A., Mombiela, T., Fernández, A. I., Martínez‐Legazpi, P., Yotti, R., Orta, R. G., Sanchez, P. L., Castaño, M., Segovia, J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019949 · Cited by 41
Pregnancy and pulmonary arterial hypertension: a case series and literature review
Yang, J. Z., Fernandes, T. M., Kim, N. H., Poch, D. S., Kerr, K. M., Lombardi, S., Melber, D. J., Kelly, T. F., & Papamatheakis, D. G. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100358 · Cited by 41
Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
Beshay, S. M., Guha, A., & Sahay, S. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/ocdf4453 · Cited by 41
Pulmonary hypertension in the child with bronchopulmonary dysplasia
Malloy, K. W., & Austin, E. D. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25602 · Cited by 41
Wang, H., Chen, R. B., Zhang, S. N., & Zhang, R. F. (2022) · BMC Genomics · doi:10.1186/s12864-021-08188-8 · Cited by 41
Pulmonary hypertension at high altitude
Naeije, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.00985-2019 · Cited by 41
Ghadimi, K., Cappiello, J. L., Cooter, M. L., Levy, J. H., Bryner, B. S., DeVore, A. D., Schroder, J. N., Patel, C. B., Rajagopal, S., Shah, S. H., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062464 · Cited by 40
Manzi, L., Sperandeo, L., Forzano, I., Castiello, D. S., Florimonte, D., Paolillo, R., Santoro, C., Mancusi, C., Serafino, L. D., Esposito, G., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14020136 · Cited by 40
Basyal, B., Jarrett, H., & Barnett, C. F. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.01.005 · Cited by 40
Santaniello, A., Casella, R., Vicenzi, M., Rota, I., Montanelli, G., Santis, M. D., Bellocchi, C., Lombardi, F., & Beretta, L. (2019) · Rheumatology · doi:10.1093/rheumatology/kez473 · Cited by 40
Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry
Medrek, S. K., Sahay, S., Zhao, C., Selej, M., & Frost, A. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.11.024 · Cited by 40
Animal models of right heart failure
Andersen, A., van der Feen, D. E., Andersen, S., Schultz, J. G., Hansmann, G., & Bogaard, H. J. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-400 · Cited by 40
Riociguat: Clinical research and evolving role in therapy
Klinger, J. R., Chakinala, M. M., Langleben, D., Rosenkranz, S., & Sitbon, O. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14676 · Cited by 40
Zheng, W., Wang, Z., Jiang, X., Zhao, Q., & Shen, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01093 · Cited by 40
Pulmonary Hypertension in Left Heart Disease
Reddy, Y. N. V., & Borlaug, B. A. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.11.002 · Cited by 40
Hu, X., & Zhang, L. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.011 · Cited by 40
Advances in the management of pulmonary arterial hypertension
Deshwal, H., Weinstein, T., & Sulica, R. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002027 · Cited by 40
Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort
van Wezenbeek, J., Groeneveldt, J. A., Valldeperas, A. L., van der Bruggen, C. E. E., Jansen, S. M. A., Smits, J., Smal, R., van Leeuwen, J. W., dos Remedios, C. G., KEOGH, A. M., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.11.004 · Cited by 40
Senescence Alterations in Pulmonary Hypertension
Roger, I., Milara, J., Belhadj, N., & Cortijo, J. (2021) · Cells · doi:10.3390/cells10123456 · Cited by 40
Pulmonary Hypertension in Pregnancy: Challenges and Solutions
Afify, H. M. A., Kong, A., Bernal, J., & Elgendy, I. Y. (2022) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s242242 · Cited by 40
An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
Gomes, J., Gandra, I., Adão, R., Perros, F., & Brás‐Silva, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.924873 · Cited by 40
Pulmonary hypertension mortality trends in United States 1999–2019
Kang, M., Hart, C. M., Kempker, J. A., Veeraraghavan, S., & Trammell, A. W. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2022.09.001 · Cited by 40
Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment
Behr, J., & Nathan, S. D. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000790 · Cited by 40
Lai, W., Ding, Y., & Wen, L. (2021) · Pulmonary Circulation · doi:10.1177/2045894020966876 · Cited by 39
Nathan, S. D., Chandel, A., Wang, Y., Xu, J., Shao, L., Watkins, T. R., Diviney, J., King, C. S., & Han, L. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.11.005 · Cited by 39
Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review
Zhang, J., Mao-mao, Shao, M., & Wang, M. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155535 · Cited by 39
Modern Right Heart Catheterization: Beyond Simple Hemodynamics
Bonno, E. L., Viray, M. C., Jackson, G. R., Houston, B. A., & Tedford, R. J. (2020) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-19.1.6 · Cited by 39
Yan, S., Resta, T. C., & Jernigan, N. L. (2020) · Antioxidants · doi:10.3390/antiox9100999 · Cited by 39
Halofuginone, a promising drug for treatment of pulmonary hypertension
Jain, P., Zhao, T., Xiong, M., Song, S., Lai, N., Zheng, Q., Chen, J., Carr, S. G., Babicheva, A., Izadi, A., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15442 · Cited by 39
Arterial load and right ventricular-vascular coupling in pulmonary hypertension
Oakland, H. T., Joseph, P., Naeije, R., Elassal, A., Cullinan, M., Heerdt, P. M., & Singh, I. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00204.2021 · Cited by 39
Prisco, S. Z., Eklund, M., Raveendran, R. M., Thenappan, T., & Prins, K. W. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.09.004 · Cited by 39
Hirsch, K., Nolley, S. H., Ralph, D. D., Zheng, Y. Y., Altemeier, W. A., Rhodes, C. J., Morrell, N. W., Wilkins, M. R., Leary, P. J., & Rayner, S. G. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.026 · Cited by 39
Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension: Role of Radiologists
Hahn, L. D., Papamatheakis, D. G., Fernandes, T. M., Poch, D. S., Yang, J. Z., Shen, J., Hoh, C. K., Hsiao, A., Kerr, K. M., Pretorius, V. G., et al. (2022) · Radiographics · doi:10.1148/rg.220078 · Cited by 39
Louw, E. H., Baines, N., Maarman, G. J., Osman, M., Sigwadhi, L. N., Irusen, E. M., Koegelenberg, C. F. N., Doubell, A. F., Nathan, S. D., Channick, R. N., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12184 · Cited by 39
Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension
Breault, N. M., Wu, D., Dasgupta, A., Chen, K., & Archer, S. L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1105565 · Cited by 39
Large Language Models with Retrieval-Augmented Generation for Zero-Shot Disease PhenotypingPreprint
Thompson, W. E., Vidmar, D., Freitas, J. K. D., Pfeifer, J. M., Fornwalt, B. K., Chen, R., Altay, G., Manghnani, K., Nelsen, A. C., Morland, K., et al. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2312.06457 · Cited by 39
Mitochondrial dysfunction in pulmonary arterial hypertension
Zhang, W., Liu, B., Wang, Y., Zhang, H., He, L., Wang, P., & Dong, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1079989 · Cited by 38
Holzer, R. J., Bergersen, L. J., Thomson, J. D., Aboulhosn, J., Aggarwal, V., Akagi, T., Alwi, M., Armstrong, A. K., BACHA, E. A., Benson, L. N., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.11.001 · Cited by 38
Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023)
Chazova, I. E., Martynyuk, T. V., Shmalts, A. A., Владимирович, Г. В., Danilov, N. M., Veselova, T. N., Захаровна, К. И., Шогаибович, С. А., Стукалова, О. В., Азизов, В. А., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-1-6-85 · Cited by 38
Fauvel, C., Damy, T., Berthelot, E., Bauer, F., Eicher, J., de Groote, P., Trochu, J., Picard, F., Renard, S., Bouvaist, H., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae467 · Cited by 38
Arvanitaki, A., Boutsikou, M., Anthi, A., Apostolopoulou, S. C., Avgeropoulou, A., Demerouti, E., Farmakis, D. T., Feloukidis, C., Giannakoulas, G. A., Karvounis, H. I., et al. (2019) · Pulmonary Circulation · doi:10.1177/2045894019877157 · Cited by 38
Pulmonary hypertension in low- and middle-income countries with focus on sub-Saharan Africa
Dzudié, A., Dzekem, B. S., Ojji, D. B., Kengne, A. P., Mocumbi, A. O., Sliwa, K. S., & Thienemann, F. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.07.06 · Cited by 38
Sadd, C. J., Osman, F., Li, Z., Chybowski, A., Decker, C., Henderson, B., Goss, K. N., Hammel, L. L., & Runo, J. R. (2020) · Transplantation · doi:10.1097/tp.0000000000003248 · Cited by 38
Pulmonary capillary haemangiomatosis: a distinct entity?
Weatherald, J. C., Dorfmüller, P., Perros, F., Ghigna, M., Girerd, B., Humbert, M. J. C., & Montani, D. (2020) · European Respiratory Review · doi:10.1183/16000617.0168-2019 · Cited by 38
Self-citationAryal, S. R., Sharifov, O. F., & Lloyd, S. G. (2020) · European Respiratory Review · doi:10.1183/16000617.0138-2019 · Cited by 38
Normal and Abnormal Relationships of Pulmonary Artery to Wedge Pressure During Exercise
Bentley, R. F., Barker, M., Esfandiari, S., Wright, S. P., Valle, F. H., Granton, J. T., & Mak, S. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016339 · Cited by 38
Smolders, V. F. E. D., Lodder, K., Rodríguez, C., Tura-Ceide, O., Barberà, J. A., Jukema, J. W., Quax, P. H. A., Goumans, M., & Kurakula, K. (2021) · Cells · doi:10.3390/cells10040737 · Cited by 38
Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases
Mehta, M., Paudel, K. R., Shukla, S. D., Allam, V. S. R. R., Kannaujiya, V. K., Panth, N., Das, A. K., Parihar, V. K., Chakraborty, A., Ali, M. K., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.010 · Cited by 38
Tuberous sclerosis complex for the pulmonologist
Rebaine, Y., Nasser, M., Girerd, B., Leroux, C., & Cottin, V. (2021) · European Respiratory Review · doi:10.1183/16000617.0348-2020 · Cited by 38
Carta, A. F., Lichtblau, M., Berlier, C., Saxer, S., Schneider, S., Schwarz, E. I., Furian, M., Bloch, K. E., & Ulrich, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.791423 · Cited by 38
Smolders, V. F. E. D., Rodríguez, C., Blanco, I., Szulcek, R., Timens, W., Piccari, L., Roger, Y., Hu, X., Morén, C., Bonjoch, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06238-z · Cited by 38
Li, M., Ying, M., Gu, S., Zhou, Z., & Zhao, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121192 · Cited by 38
Wang, R., Huang, S., Waldo, S. W., Hess, E., Gokhale, M., Johnson, S. W., Zeder, K., Choudhary, G., Leopold, J. A., Oldham, W. M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202211-2097oc · Cited by 38
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Benedetto, P. D., Guggino, G., Manzi, G., Ruscitti, P., Berardicurti, O., Panzera, N., Grazia, N., Badagliacca, R., Riccieri, V., Vizza, C. D., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02218-8 · Cited by 38
Pulmonary veno-occlusive disease: illustrative cases and literature review
Lechartier, B., Boucly, A., Solinas, S., Gopalan, D., Dorfmüller, P., Radonic, T., Sitbon, O., & Montani, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0156-2023 · Cited by 37
Self-citationRodríguez-Pérez, J., Andreu-Martínez, R., Daza, R., Fernández-Arroyo, L., Hernández-García, A., Díaz‐García, E., Cubillos‐Zapata, C., Lozano-Díez, A., Morales, A., Ramos, D., et al. (2025) · Antioxidants · doi:10.3390/antiox14070839 · Cited by 38
Forestier, A., Gouellec, N. L., Behal, H., Kramer, G. B. G., Perez, T., Sobanski, V., Morell‐Dubois, S., Lambert, M., Hatron, P., HACHULLA, E., et al. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.02.015 · Cited by 37
TBX4 variants and pulmonary diseases: getting out of the ‘Box’
Haarman, M. G., Kerstjens‐Frederikse, W. S., & Berger, R. M. F. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000678 · Cited by 37
The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension
He, S., Zhu, T., & Fang, Z. (2020) · International Journal of Hypertension · doi:10.1155/2020/1478291 · Cited by 37
Lambert, M., Mendes‐Ferreira, P., Ghigna, M., Ribeuz, H. L., Adão, R., Boët, A., Capuano, V., Rücker‐Martin, C., Brás‐Silva, C., Quarck, R. A., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab016 · Cited by 37
Self-citationExercise right ventricular ejection fraction predicts right ventricular contractile reserve
Ireland, C. G., Damico, R. L., Kolb, T. M., Mathai, S. C., Mukherjee, M., Zimmerman, S. L., Shah, A. A., Wigley, F. M., Houston, B. A., Hassoun, P. M., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.02.005 · Cited by 37
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Ribeuz, H. L., To, L., Ghigna, M., Martin, C., Nagaraj, C., Dréano, E., Rücker‐Martin, C., Girerd, B., Bouligand, J., Péchoux, C., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00653-2020 · Cited by 37
Self-citationLi, Y., Guo, D., Gong, J., Wang, J., Huang, Q., Yang, S., Zhang, X., Hu, H., Jiang, Z., Yang, Y., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.690606 · Cited by 37
Vanderpool, R. R., Hunter, K. S., Insel, M. B., Garcia, J. G. N., Bedrick, E. J., Tedford, R. J., & Rischard, F. P. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.09.040 · Cited by 37
Computational repurposing of therapeutic small molecules from cancer to pulmonary hypertension
Negi, V., Yang, J., Speyer, G., Pulgarin, A., Handen, A. L., Zhao, J., Tai, Y., Tang, Y., Culley, M. K., Yu, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh3794 · Cited by 37
Sun, X., Nakajima, E., Norbrun, C., Sorkhdini, P., Yang, A. X., Yang, D., Ventetuolo, C. E., Braza, J., Vang, A., Aliotta, J. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159578 · Cited by 37
González-Hermosillo, L.-M., Cueto‐Robledo, G., Roldán-Valadéz, E., Graniel-Palafox, L.-E., García‐Cesar, M., Torres-Rojas, M.-B., Romero-Martinez, B., & Castro-Escalante, K.-Y. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101351 · Cited by 37
Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis
Martens, P., Bhattacharya, S., Longinow, J., Ives, L., Jacob, M. S., Valent, J. N., Hanna, M. A., & Tang, W. H. W. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.010078 · Cited by 37
Pericytes contribute to pulmonary vascular remodeling via HIF2α signaling
Kim, H., Liu, Y., Kim, J. J., Kim, Y., Klouda, T. M., Fisch, S., Baek, S. H., Liu, T., Dahlberg, S. E., Hu, C., et al. (2024) · EMBO Reports · doi:10.1038/s44319-023-00054-w · Cited by 37
Riou, M., Alfatni, A., Charles, A., Andrès, E., Pistea, C., Charloux, A., & Gény, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051253 · Cited by 37
Shahin, Y., Alabed, S., Alkhanfar, D., Tschirren, J., Rothman, A. M. K., Condliffe, R. A., Wild, J. M., Kiely, D. G., & Swift, A. J. (2022) · Radiology · doi:10.1148/radiol.210482 · Cited by 36
Weatherald, J. C., Nathan, S. D., El‐Kersh, K., Argula, R. G., DuBrock, H. M., Rischard, F. P., Cassady, S. J., Tarver, J., Levine, D. J., Tapson, V. F., et al. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-002116 · Cited by 36
Tura-Ceide, O., Smolders, V. F. E. D., Aventín, N., Morén, C., Guitart‐Mampel, M., Blanco, I., Piccari, L., Osorio, J., Rodríguez, C., Rigol, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98320-1 · Cited by 36
Practical approach to establishing pulmonary rehabilitation for people with non‐COPD diagnoses
Granger, C. L., Morris, N. R., & Holland, A. E. (2019) · Respirology · doi:10.1111/resp.13562 · Cited by 36
Wright, S. P., Groves, L. A., Vishram‐Nielsen, J. K. K., Karvasarski, E., Valle, F. H., Alba, A. C., & Mak, S. S. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.02.013 · Cited by 36
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
Attanasio, U., Cuomo, A., Pirozzi, F., Loffredo, S., Abete, P., Petretta, M., Marone, G., Bonaduce, D., de Paulis, A., Rossi, F. W., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124430 · Cited by 36
Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies
Spaczyńska-Kwiatkowska, M., Rocha, S. F., & Oliver, E. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00048 · Cited by 36
Portopulmonary Hypertension: Prevalence, Clinical and Hemodynamic Features
Navarro-Vergara, D.-I., Roldán-Valadéz, E., Cueto‐Robledo, G., & Jurado-Hernandez, M. Y. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100747 · Cited by 36
A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension
Colebank, M. J., Qureshi, M. U., Rajagopal, S., Krasuski, R. A., & Olufsen, M. S. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00086.2021 · Cited by 36
Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome
Stevens, R. P., Paudel, S. S., Johnson, S., Stevens, T., & Lee, J. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00131.2021 · Cited by 36
Medicinal Plants Used in the Treatment of Pulmonary Hypertension
Adetunji, C. O., Olaniyan, O. T., Akram, M., Ajayi, O. O., Inobeme, A., Olaniyan, S., Khan, F. S., & Adetunji, J. B. (2021) · Springer eBooks · doi:10.1007/978-981-33-6850-7_14 · Cited by 36
Role of the Immune System Elements in Pulmonary Arterial Hypertension
Tomaszewski, M., Bębnowska, D., Hrynkiewicz, R., Dworzyński, J., Niedźwiedzka‐Rystwej, P., Kopeć, G., & Grywalska, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163757 · Cited by 36
Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia
Cueto‐Robledo, G., Porres‐Aguilar, M., Puebla-Aldama, D., Barragan-Martinez, M.-D.-P., Jurado-Hernandez, M. Y., García‐Cesar, M., Torres-Rojas, M.-B., García-Treminio, C., & Roldán-Valadéz, E. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.101004 · Cited by 36
Hu, L., Zhao, C., Chen, Z., Hu, G., Li, X., & Li, Q. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.011 · Cited by 36
Chazova, I. E., Ageev, F. T., Владимировна, А. А., Vicenya, M. V. V., Gilyarov, M. Y., Martynyuk, T. V., Панченко, Е. П., Poltavskaya, M. G., Potievskaya, V. I., Trofimova, O. P., et al. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-1-6-79 · Cited by 36
Hlavaty, A., Roustit, M., Montani, D., Chaumais, M., Guignabert, C., Humbert, M. J. C., Cracowski, J., & Khouri, C. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15436 · Cited by 36
Self-citationBrittain, E. L., Thenappan, T., Huston, J., Agrawal, V., Lai, Y., Dixon, D., Ryan, J. J., Lewis, E. F., Redfield, M. M., Shah, S. J., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001079 · Cited by 36
Aßmus, B., Angermann, C. E., Alkhlout, B., Asselbergs, F. W., Schnupp, S., Brugts, J. J., Nordbeck, P., Zhou, Q., Brett, M., Ginn, G., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2656 · Cited by 36
Li, B., Teng, C., Yu, H., Jiang, X., Xing, X., Jiang, Q., Lin, C., Zhao, Z., Zhang, R., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.002 · Cited by 36
Parameter inference in a computational model of haemodynamics in pulmonary hypertension
Colunga, A. L., Colebank, M. J., Program, R., & Olufsen, M. S. (2023) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0735 · Cited by 36
Portopulmonary Hypertension: An Updated Review
Jasso-Baltazar, E. A., Peña-Arellano, G. A., Aguirre-Valádez, J., Ruiz, I., Papacristofilou-Riebeling, B., Jiménez, J. V., García-Carrera, C. J., Rivera-Lopez, F. E., Rodriguez-Andoney, J., Lima-López, F., et al. (2023) · Transplantation Direct · doi:10.1097/txd.0000000000001517 · Cited by 36
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.